nodes	percent_of_prediction	percent_of_DWPC	metapath
Flecainide—CYP2C9—Capecitabine—colon cancer	0.104	0.628	CbGbCtD
Flecainide—CYP2C9—Fluorouracil—colon cancer	0.0617	0.372	CbGbCtD
Flecainide—Mefloquine—ABCB1—colon cancer	0.0185	1	CrCbGaD
Flecainide—Flushing—Irinotecan—colon cancer	0.00283	0.00347	CcSEcCtD
Flecainide—Cardiac arrest—Capecitabine—colon cancer	0.0028	0.00344	CcSEcCtD
Flecainide—Urinary retention—Capecitabine—colon cancer	0.0028	0.00344	CcSEcCtD
Flecainide—Ataxia—Capecitabine—colon cancer	0.00277	0.0034	CcSEcCtD
Flecainide—Alopecia—Vincristine—colon cancer	0.00277	0.00339	CcSEcCtD
Flecainide—Coma—Methotrexate—colon cancer	0.00276	0.00339	CcSEcCtD
Flecainide—Immune system disorder—Irinotecan—colon cancer	0.00275	0.00337	CcSEcCtD
Flecainide—Urine output increased—Methotrexate—colon cancer	0.00273	0.00335	CcSEcCtD
Flecainide—Gynaecomastia—Methotrexate—colon cancer	0.00271	0.00332	CcSEcCtD
Flecainide—Alopecia—Irinotecan—colon cancer	0.00269	0.0033	CcSEcCtD
Flecainide—Pulmonary oedema—Methotrexate—colon cancer	0.00269	0.0033	CcSEcCtD
Flecainide—Flatulence—Irinotecan—colon cancer	0.00261	0.00321	CcSEcCtD
Flecainide—Alopecia—Fluorouracil—colon cancer	0.00258	0.00316	CcSEcCtD
Flecainide—Bronchospasm—Capecitabine—colon cancer	0.00251	0.00307	CcSEcCtD
Flecainide—Polyuria—Methotrexate—colon cancer	0.0025	0.00306	CcSEcCtD
Flecainide—Angina pectoris—Capecitabine—colon cancer	0.00248	0.00304	CcSEcCtD
Flecainide—Sweating increased—Capecitabine—colon cancer	0.00248	0.00304	CcSEcCtD
Flecainide—Ill-defined disorder—Irinotecan—colon cancer	0.00246	0.00302	CcSEcCtD
Flecainide—Vertigo—Vincristine—colon cancer	0.00245	0.003	CcSEcCtD
Flecainide—Hepatic failure—Methotrexate—colon cancer	0.00244	0.00299	CcSEcCtD
Flecainide—Leukopenia—Vincristine—colon cancer	0.00244	0.00299	CcSEcCtD
Flecainide—Vision blurred—Fluorouracil—colon cancer	0.00239	0.00294	CcSEcCtD
Flecainide—Malaise—Irinotecan—colon cancer	0.00239	0.00293	CcSEcCtD
Flecainide—Vertigo—Irinotecan—colon cancer	0.00238	0.00292	CcSEcCtD
Flecainide—Dysuria—Capecitabine—colon cancer	0.00238	0.00292	CcSEcCtD
Flecainide—Syncope—Irinotecan—colon cancer	0.00238	0.00292	CcSEcCtD
Flecainide—Leukopenia—Irinotecan—colon cancer	0.00237	0.00291	CcSEcCtD
Flecainide—Convulsion—Vincristine—colon cancer	0.00236	0.00289	CcSEcCtD
Flecainide—Hypertension—Vincristine—colon cancer	0.00235	0.00288	CcSEcCtD
Flecainide—Loss of consciousness—Irinotecan—colon cancer	0.00233	0.00286	CcSEcCtD
Flecainide—Dermatitis exfoliative—Methotrexate—colon cancer	0.00233	0.00285	CcSEcCtD
Flecainide—Photosensitivity reaction—Capecitabine—colon cancer	0.00233	0.00285	CcSEcCtD
Flecainide—Myalgia—Vincristine—colon cancer	0.00232	0.00284	CcSEcCtD
Flecainide—Visual disturbance—Methotrexate—colon cancer	0.00232	0.00284	CcSEcCtD
Flecainide—Cough—Irinotecan—colon cancer	0.00232	0.00284	CcSEcCtD
Flecainide—Hyperglycaemia—Capecitabine—colon cancer	0.0023	0.00282	CcSEcCtD
Flecainide—Hypertension—Irinotecan—colon cancer	0.00229	0.00281	CcSEcCtD
Flecainide—Pneumonia—Capecitabine—colon cancer	0.00229	0.0028	CcSEcCtD
Flecainide—Leukopenia—Fluorouracil—colon cancer	0.00227	0.00279	CcSEcCtD
Flecainide—Renal failure—Capecitabine—colon cancer	0.00223	0.00274	CcSEcCtD
Flecainide—Discomfort—Irinotecan—colon cancer	0.00223	0.00274	CcSEcCtD
Flecainide—Neuropathy peripheral—Capecitabine—colon cancer	0.00223	0.00273	CcSEcCtD
Flecainide—Oedema—Vincristine—colon cancer	0.00222	0.00273	CcSEcCtD
Flecainide—Jaundice—Capecitabine—colon cancer	0.00221	0.00272	CcSEcCtD
Flecainide—Convulsion—Fluorouracil—colon cancer	0.0022	0.0027	CcSEcCtD
Flecainide—Confusional state—Irinotecan—colon cancer	0.00218	0.00268	CcSEcCtD
Flecainide—Nervous system disorder—Vincristine—colon cancer	0.00218	0.00267	CcSEcCtD
Flecainide—Thrombocytopenia—Vincristine—colon cancer	0.00218	0.00267	CcSEcCtD
Flecainide—Haematuria—Capecitabine—colon cancer	0.00217	0.00266	CcSEcCtD
Flecainide—Oedema—Irinotecan—colon cancer	0.00217	0.00265	CcSEcCtD
Flecainide—Chest pain—Fluorouracil—colon cancer	0.00216	0.00265	CcSEcCtD
Flecainide—Myalgia—Fluorouracil—colon cancer	0.00216	0.00265	CcSEcCtD
Flecainide—Hyperhidrosis—Vincristine—colon cancer	0.00215	0.00264	CcSEcCtD
Flecainide—Discomfort—Fluorouracil—colon cancer	0.00214	0.00262	CcSEcCtD
Flecainide—Shock—Irinotecan—colon cancer	0.00213	0.00261	CcSEcCtD
Flecainide—Nervous system disorder—Irinotecan—colon cancer	0.00212	0.0026	CcSEcCtD
Flecainide—Agranulocytosis—Capecitabine—colon cancer	0.00212	0.0026	CcSEcCtD
Flecainide—Thrombocytopenia—Irinotecan—colon cancer	0.00212	0.0026	CcSEcCtD
Flecainide—Anorexia—Vincristine—colon cancer	0.00212	0.0026	CcSEcCtD
Flecainide—Hyperhidrosis—Irinotecan—colon cancer	0.00209	0.00257	CcSEcCtD
Flecainide—Confusional state—Fluorouracil—colon cancer	0.00209	0.00256	CcSEcCtD
Flecainide—Hypotension—Vincristine—colon cancer	0.00208	0.00255	CcSEcCtD
Flecainide—Bradycardia—Capecitabine—colon cancer	0.00208	0.00255	CcSEcCtD
Flecainide—Oedema—Fluorouracil—colon cancer	0.00207	0.00254	CcSEcCtD
Flecainide—Anorexia—Irinotecan—colon cancer	0.00206	0.00253	CcSEcCtD
Flecainide—Ataxia—Methotrexate—colon cancer	0.00206	0.00253	CcSEcCtD
Flecainide—Nervous system disorder—Fluorouracil—colon cancer	0.00203	0.00249	CcSEcCtD
Flecainide—Thrombocytopenia—Fluorouracil—colon cancer	0.00203	0.00249	CcSEcCtD
Flecainide—Hypoaesthesia—Capecitabine—colon cancer	0.00203	0.00249	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Vincristine—colon cancer	0.00203	0.00248	CcSEcCtD
Flecainide—Tachycardia—Fluorouracil—colon cancer	0.00202	0.00248	CcSEcCtD
Flecainide—Hypotension—Irinotecan—colon cancer	0.00202	0.00248	CcSEcCtD
Flecainide—Insomnia—Vincristine—colon cancer	0.00201	0.00247	CcSEcCtD
Flecainide—Paraesthesia—Vincristine—colon cancer	0.002	0.00245	CcSEcCtD
Flecainide—Anorexia—Fluorouracil—colon cancer	0.00198	0.00242	CcSEcCtD
Flecainide—Visual impairment—Capecitabine—colon cancer	0.00197	0.00241	CcSEcCtD
Flecainide—Insomnia—Irinotecan—colon cancer	0.00196	0.0024	CcSEcCtD
Flecainide—Paraesthesia—Irinotecan—colon cancer	0.00194	0.00238	CcSEcCtD
Flecainide—Hypotension—Fluorouracil—colon cancer	0.00194	0.00238	CcSEcCtD
Flecainide—Decreased appetite—Vincristine—colon cancer	0.00193	0.00237	CcSEcCtD
Flecainide—Dyspnoea—Irinotecan—colon cancer	0.00193	0.00237	CcSEcCtD
Flecainide—Somnolence—Irinotecan—colon cancer	0.00193	0.00236	CcSEcCtD
Flecainide—Gastrointestinal disorder—Vincristine—colon cancer	0.00192	0.00235	CcSEcCtD
Flecainide—Fatigue—Vincristine—colon cancer	0.00192	0.00235	CcSEcCtD
Flecainide—Eye disorder—Capecitabine—colon cancer	0.00191	0.00234	CcSEcCtD
Flecainide—Dyspepsia—Irinotecan—colon cancer	0.00191	0.00234	CcSEcCtD
Flecainide—Tinnitus—Capecitabine—colon cancer	0.0019	0.00233	CcSEcCtD
Flecainide—Constipation—Vincristine—colon cancer	0.0019	0.00233	CcSEcCtD
Flecainide—Pain—Vincristine—colon cancer	0.0019	0.00233	CcSEcCtD
Flecainide—Flushing—Capecitabine—colon cancer	0.00189	0.00232	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00189	0.00232	CcSEcCtD
Flecainide—Decreased appetite—Irinotecan—colon cancer	0.00188	0.00231	CcSEcCtD
Flecainide—Insomnia—Fluorouracil—colon cancer	0.00188	0.0023	CcSEcCtD
Flecainide—Gastrointestinal disorder—Irinotecan—colon cancer	0.00187	0.00229	CcSEcCtD
Flecainide—Fatigue—Irinotecan—colon cancer	0.00187	0.00229	CcSEcCtD
Flecainide—Paraesthesia—Fluorouracil—colon cancer	0.00186	0.00228	CcSEcCtD
Flecainide—Pain—Irinotecan—colon cancer	0.00185	0.00227	CcSEcCtD
Flecainide—Constipation—Irinotecan—colon cancer	0.00185	0.00227	CcSEcCtD
Flecainide—Dyspnoea—Fluorouracil—colon cancer	0.00185	0.00227	CcSEcCtD
Flecainide—Somnolence—Fluorouracil—colon cancer	0.00184	0.00226	CcSEcCtD
Flecainide—Immune system disorder—Capecitabine—colon cancer	0.00184	0.00226	CcSEcCtD
Flecainide—Dyspepsia—Fluorouracil—colon cancer	0.00183	0.00224	CcSEcCtD
Flecainide—Gastrointestinal pain—Vincristine—colon cancer	0.00182	0.00223	CcSEcCtD
Flecainide—Decreased appetite—Fluorouracil—colon cancer	0.0018	0.00221	CcSEcCtD
Flecainide—Alopecia—Capecitabine—colon cancer	0.0018	0.00221	CcSEcCtD
Flecainide—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00179	0.00219	CcSEcCtD
Flecainide—Feeling abnormal—Irinotecan—colon cancer	0.00178	0.00219	CcSEcCtD
Flecainide—Dysuria—Methotrexate—colon cancer	0.00177	0.00217	CcSEcCtD
Flecainide—Pain—Fluorouracil—colon cancer	0.00177	0.00217	CcSEcCtD
Flecainide—Gastrointestinal pain—Irinotecan—colon cancer	0.00177	0.00217	CcSEcCtD
Flecainide—Abdominal pain—Vincristine—colon cancer	0.00176	0.00215	CcSEcCtD
Flecainide—Body temperature increased—Vincristine—colon cancer	0.00176	0.00215	CcSEcCtD
Flecainide—Flatulence—Capecitabine—colon cancer	0.00175	0.00215	CcSEcCtD
Flecainide—Erectile dysfunction—Methotrexate—colon cancer	0.00175	0.00214	CcSEcCtD
Flecainide—Dysgeusia—Capecitabine—colon cancer	0.00174	0.00213	CcSEcCtD
Flecainide—Photosensitivity reaction—Methotrexate—colon cancer	0.00173	0.00212	CcSEcCtD
Flecainide—Body temperature increased—Irinotecan—colon cancer	0.00171	0.0021	CcSEcCtD
Flecainide—Abdominal pain—Irinotecan—colon cancer	0.00171	0.0021	CcSEcCtD
Flecainide—Feeling abnormal—Fluorouracil—colon cancer	0.00171	0.0021	CcSEcCtD
Flecainide—Pneumonia—Methotrexate—colon cancer	0.0017	0.00209	CcSEcCtD
Flecainide—Vision blurred—Capecitabine—colon cancer	0.00167	0.00205	CcSEcCtD
Flecainide—Tremor—Capecitabine—colon cancer	0.00166	0.00204	CcSEcCtD
Flecainide—Renal failure—Methotrexate—colon cancer	0.00166	0.00204	CcSEcCtD
Flecainide—Ill-defined disorder—Capecitabine—colon cancer	0.00165	0.00202	CcSEcCtD
Flecainide—Urticaria—Fluorouracil—colon cancer	0.00165	0.00202	CcSEcCtD
Flecainide—Body temperature increased—Fluorouracil—colon cancer	0.00164	0.00201	CcSEcCtD
Flecainide—Haematuria—Methotrexate—colon cancer	0.00161	0.00198	CcSEcCtD
Flecainide—Malaise—Capecitabine—colon cancer	0.0016	0.00196	CcSEcCtD
Flecainide—Vertigo—Capecitabine—colon cancer	0.0016	0.00196	CcSEcCtD
Flecainide—Asthenia—Vincristine—colon cancer	0.0016	0.00196	CcSEcCtD
Flecainide—Syncope—Capecitabine—colon cancer	0.00159	0.00195	CcSEcCtD
Flecainide—Leukopenia—Capecitabine—colon cancer	0.00159	0.00195	CcSEcCtD
Flecainide—Agranulocytosis—Methotrexate—colon cancer	0.00158	0.00194	CcSEcCtD
Flecainide—Palpitations—Capecitabine—colon cancer	0.00157	0.00192	CcSEcCtD
Flecainide—Loss of consciousness—Capecitabine—colon cancer	0.00156	0.00191	CcSEcCtD
Flecainide—Asthenia—Irinotecan—colon cancer	0.00155	0.0019	CcSEcCtD
Flecainide—Cough—Capecitabine—colon cancer	0.00155	0.0019	CcSEcCtD
Flecainide—Hypertension—Capecitabine—colon cancer	0.00153	0.00188	CcSEcCtD
Flecainide—Diarrhoea—Vincristine—colon cancer	0.00152	0.00186	CcSEcCtD
Flecainide—Myalgia—Capecitabine—colon cancer	0.00151	0.00185	CcSEcCtD
Flecainide—Chest pain—Capecitabine—colon cancer	0.00151	0.00185	CcSEcCtD
Flecainide—Arthralgia—Capecitabine—colon cancer	0.00151	0.00185	CcSEcCtD
Flecainide—Anxiety—Capecitabine—colon cancer	0.00151	0.00185	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.0015	0.00184	CcSEcCtD
Flecainide—Discomfort—Capecitabine—colon cancer	0.00149	0.00183	CcSEcCtD
Flecainide—Diarrhoea—Irinotecan—colon cancer	0.00148	0.00182	CcSEcCtD
Flecainide—Dry mouth—Capecitabine—colon cancer	0.00148	0.00181	CcSEcCtD
Flecainide—Dizziness—Vincristine—colon cancer	0.00147	0.0018	CcSEcCtD
Flecainide—Pruritus—Fluorouracil—colon cancer	0.00147	0.0018	CcSEcCtD
Flecainide—Visual impairment—Methotrexate—colon cancer	0.00146	0.00179	CcSEcCtD
Flecainide—Confusional state—Capecitabine—colon cancer	0.00146	0.00179	CcSEcCtD
Flecainide—Oedema—Capecitabine—colon cancer	0.00145	0.00178	CcSEcCtD
Flecainide—Dizziness—Irinotecan—colon cancer	0.00143	0.00176	CcSEcCtD
Flecainide—Shock—Capecitabine—colon cancer	0.00143	0.00175	CcSEcCtD
Flecainide—Nervous system disorder—Capecitabine—colon cancer	0.00142	0.00174	CcSEcCtD
Flecainide—Eye disorder—Methotrexate—colon cancer	0.00142	0.00174	CcSEcCtD
Flecainide—Diarrhoea—Fluorouracil—colon cancer	0.00142	0.00174	CcSEcCtD
Flecainide—Thrombocytopenia—Capecitabine—colon cancer	0.00142	0.00174	CcSEcCtD
Flecainide—Tinnitus—Methotrexate—colon cancer	0.00142	0.00174	CcSEcCtD
Flecainide—Tachycardia—Capecitabine—colon cancer	0.00141	0.00173	CcSEcCtD
Flecainide—Vomiting—Vincristine—colon cancer	0.00141	0.00173	CcSEcCtD
Flecainide—Skin disorder—Capecitabine—colon cancer	0.00141	0.00173	CcSEcCtD
Flecainide—Rash—Vincristine—colon cancer	0.0014	0.00172	CcSEcCtD
Flecainide—Hyperhidrosis—Capecitabine—colon cancer	0.0014	0.00172	CcSEcCtD
Flecainide—Dermatitis—Vincristine—colon cancer	0.0014	0.00172	CcSEcCtD
Flecainide—Headache—Vincristine—colon cancer	0.00139	0.00171	CcSEcCtD
Flecainide—Anorexia—Capecitabine—colon cancer	0.00138	0.00169	CcSEcCtD
Flecainide—Vomiting—Irinotecan—colon cancer	0.00138	0.00169	CcSEcCtD
Flecainide—Immune system disorder—Methotrexate—colon cancer	0.00137	0.00168	CcSEcCtD
Flecainide—Dizziness—Fluorouracil—colon cancer	0.00137	0.00168	CcSEcCtD
Flecainide—Rash—Irinotecan—colon cancer	0.00137	0.00167	CcSEcCtD
Flecainide—Dermatitis—Irinotecan—colon cancer	0.00136	0.00167	CcSEcCtD
Flecainide—Headache—Irinotecan—colon cancer	0.00136	0.00166	CcSEcCtD
Flecainide—Hypotension—Capecitabine—colon cancer	0.00135	0.00166	CcSEcCtD
Flecainide—Alopecia—Methotrexate—colon cancer	0.00134	0.00165	CcSEcCtD
Flecainide—Nausea—Vincristine—colon cancer	0.00132	0.00162	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00132	0.00162	CcSEcCtD
Flecainide—Vomiting—Fluorouracil—colon cancer	0.00132	0.00162	CcSEcCtD
Flecainide—Insomnia—Capecitabine—colon cancer	0.00131	0.00161	CcSEcCtD
Flecainide—Rash—Fluorouracil—colon cancer	0.00131	0.0016	CcSEcCtD
Flecainide—Dermatitis—Fluorouracil—colon cancer	0.00131	0.0016	CcSEcCtD
Flecainide—Paraesthesia—Capecitabine—colon cancer	0.0013	0.0016	CcSEcCtD
Flecainide—Headache—Fluorouracil—colon cancer	0.0013	0.00159	CcSEcCtD
Flecainide—Dysgeusia—Methotrexate—colon cancer	0.00129	0.00159	CcSEcCtD
Flecainide—Dyspnoea—Capecitabine—colon cancer	0.00129	0.00158	CcSEcCtD
Flecainide—Nausea—Irinotecan—colon cancer	0.00129	0.00158	CcSEcCtD
Flecainide—Dyspepsia—Capecitabine—colon cancer	0.00128	0.00156	CcSEcCtD
Flecainide—Decreased appetite—Capecitabine—colon cancer	0.00126	0.00154	CcSEcCtD
Flecainide—Gastrointestinal disorder—Capecitabine—colon cancer	0.00125	0.00153	CcSEcCtD
Flecainide—Fatigue—Capecitabine—colon cancer	0.00125	0.00153	CcSEcCtD
Flecainide—Vision blurred—Methotrexate—colon cancer	0.00125	0.00153	CcSEcCtD
Flecainide—Pain—Capecitabine—colon cancer	0.00124	0.00152	CcSEcCtD
Flecainide—Constipation—Capecitabine—colon cancer	0.00124	0.00152	CcSEcCtD
Flecainide—Nausea—Fluorouracil—colon cancer	0.00123	0.00151	CcSEcCtD
Flecainide—Ill-defined disorder—Methotrexate—colon cancer	0.00123	0.0015	CcSEcCtD
Flecainide—Feeling abnormal—Capecitabine—colon cancer	0.00119	0.00146	CcSEcCtD
Flecainide—Malaise—Methotrexate—colon cancer	0.00119	0.00146	CcSEcCtD
Flecainide—Vertigo—Methotrexate—colon cancer	0.00119	0.00146	CcSEcCtD
Flecainide—Gastrointestinal pain—Capecitabine—colon cancer	0.00119	0.00145	CcSEcCtD
Flecainide—Leukopenia—Methotrexate—colon cancer	0.00118	0.00145	CcSEcCtD
Flecainide—Cough—Methotrexate—colon cancer	0.00115	0.00141	CcSEcCtD
Flecainide—Urticaria—Capecitabine—colon cancer	0.00115	0.00141	CcSEcCtD
Flecainide—Abdominal pain—Capecitabine—colon cancer	0.00115	0.0014	CcSEcCtD
Flecainide—Body temperature increased—Capecitabine—colon cancer	0.00115	0.0014	CcSEcCtD
Flecainide—Convulsion—Methotrexate—colon cancer	0.00115	0.0014	CcSEcCtD
Flecainide—Arthralgia—Methotrexate—colon cancer	0.00113	0.00138	CcSEcCtD
Flecainide—Chest pain—Methotrexate—colon cancer	0.00113	0.00138	CcSEcCtD
Flecainide—Myalgia—Methotrexate—colon cancer	0.00113	0.00138	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00112	0.00137	CcSEcCtD
Flecainide—Discomfort—Methotrexate—colon cancer	0.00111	0.00136	CcSEcCtD
Flecainide—Confusional state—Methotrexate—colon cancer	0.00109	0.00133	CcSEcCtD
Flecainide—Nervous system disorder—Methotrexate—colon cancer	0.00106	0.0013	CcSEcCtD
Flecainide—Thrombocytopenia—Methotrexate—colon cancer	0.00106	0.00129	CcSEcCtD
Flecainide—Skin disorder—Methotrexate—colon cancer	0.00105	0.00128	CcSEcCtD
Flecainide—Hyperhidrosis—Methotrexate—colon cancer	0.00104	0.00128	CcSEcCtD
Flecainide—Asthenia—Capecitabine—colon cancer	0.00104	0.00127	CcSEcCtD
Flecainide—Anorexia—Methotrexate—colon cancer	0.00103	0.00126	CcSEcCtD
Flecainide—Pruritus—Capecitabine—colon cancer	0.00103	0.00126	CcSEcCtD
Flecainide—Hypotension—Methotrexate—colon cancer	0.00101	0.00124	CcSEcCtD
Flecainide—Diarrhoea—Capecitabine—colon cancer	0.000992	0.00122	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000983	0.0012	CcSEcCtD
Flecainide—Insomnia—Methotrexate—colon cancer	0.000976	0.0012	CcSEcCtD
Flecainide—Paraesthesia—Methotrexate—colon cancer	0.000969	0.00119	CcSEcCtD
Flecainide—Dyspnoea—Methotrexate—colon cancer	0.000962	0.00118	CcSEcCtD
Flecainide—Somnolence—Methotrexate—colon cancer	0.000959	0.00118	CcSEcCtD
Flecainide—Dizziness—Capecitabine—colon cancer	0.000958	0.00117	CcSEcCtD
Flecainide—Dyspepsia—Methotrexate—colon cancer	0.00095	0.00116	CcSEcCtD
Flecainide—Decreased appetite—Methotrexate—colon cancer	0.000938	0.00115	CcSEcCtD
Flecainide—Gastrointestinal disorder—Methotrexate—colon cancer	0.000931	0.00114	CcSEcCtD
Flecainide—Fatigue—Methotrexate—colon cancer	0.00093	0.00114	CcSEcCtD
Flecainide—Pain—Methotrexate—colon cancer	0.000923	0.00113	CcSEcCtD
Flecainide—Vomiting—Capecitabine—colon cancer	0.000921	0.00113	CcSEcCtD
Flecainide—Rash—Capecitabine—colon cancer	0.000914	0.00112	CcSEcCtD
Flecainide—Dermatitis—Capecitabine—colon cancer	0.000913	0.00112	CcSEcCtD
Flecainide—Headache—Capecitabine—colon cancer	0.000908	0.00111	CcSEcCtD
Flecainide—Feeling abnormal—Methotrexate—colon cancer	0.000889	0.00109	CcSEcCtD
Flecainide—Gastrointestinal pain—Methotrexate—colon cancer	0.000882	0.00108	CcSEcCtD
Flecainide—Nausea—Capecitabine—colon cancer	0.000861	0.00106	CcSEcCtD
Flecainide—Urticaria—Methotrexate—colon cancer	0.000857	0.00105	CcSEcCtD
Flecainide—Abdominal pain—Methotrexate—colon cancer	0.000853	0.00105	CcSEcCtD
Flecainide—Body temperature increased—Methotrexate—colon cancer	0.000853	0.00105	CcSEcCtD
Flecainide—Asthenia—Methotrexate—colon cancer	0.000774	0.000949	CcSEcCtD
Flecainide—Pruritus—Methotrexate—colon cancer	0.000763	0.000936	CcSEcCtD
Flecainide—Diarrhoea—Methotrexate—colon cancer	0.000738	0.000905	CcSEcCtD
Flecainide—Dizziness—Methotrexate—colon cancer	0.000713	0.000875	CcSEcCtD
Flecainide—Vomiting—Methotrexate—colon cancer	0.000686	0.000841	CcSEcCtD
Flecainide—Rash—Methotrexate—colon cancer	0.00068	0.000834	CcSEcCtD
Flecainide—Dermatitis—Methotrexate—colon cancer	0.00068	0.000833	CcSEcCtD
Flecainide—Headache—Methotrexate—colon cancer	0.000676	0.000829	CcSEcCtD
Flecainide—Nausea—Methotrexate—colon cancer	0.000641	0.000786	CcSEcCtD
